GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trialsJun 1, 2020· Chuqing Cao 1st AuthorShu-Ting YANG,Zhiguang Zhou Corresponding Author· 0 min read PMID DOIpublicationLast updated on Jun 1, 2020Journal Article AuthorsShu-Ting YANGPhysicianAn endocrinologist passionate about artificial intelligence and diabetes, focusing on applying machine learning and bioinformatics to diabetes heterogeneity research. ← Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor Jul 1, 2020Roscovitine enhances all-trans retinoic acid (ATRA)-induced nuclear enrichment of an ensemble of activated signaling molecules and augments ATRA-induced myeloid cell differentiation Mar 24, 2020 →
,